Guide to Alanine Aminotransferase (ALT)

WRITTEN BY
Updated: 05/22/2025|12 min read

Summary

Alanine aminotransferase (ALT) is an enzyme primarily found in liver cells (hepatocytes). When liver cells are damaged or die, they release ALT into the bloodstream, so ALT is one of the most reliable signs of liver health and injury.

Why It Matters

ALT serves as both a specific marker of liver health and a broader window into metabolic health. While primarily found in liver cells, its levels tell multiple stories: immediate liver cell damage (where ALT leaks into the bloodstream), ongoing liver stress (from conditions like fatty liver disease and excessive alcohol use), and overall metabolic function (through its role in amino acid processing and glucose production).

Recent research suggests ALT's significance extends beyond liver health alone. Elevated ALT is associated with metabolic syndrome, inflammation, and cardiovascular risks, but its role as an independent predictor of mortality remains an area of ongoing research.

Think of ALT as an early warning system - it rises quickly with acute liver injury but can also creep up gradually with chronic metabolic stress. This makes it valuable both for detecting immediate liver problems and for screening broader metabolic health risks before they become clinically apparent.

How To Think About Results

Rather than viewing ALT simply as a liver enzyme, consider it in the broader context of metabolic health:

Acute Changes

  • Rapid ALT elevation may indicate direct liver cell damage (from medications, alcohol, etc.)
  • These changes typically resolve within weeks if the cause is addressed
  • Very high levels (>500) require immediate medical attention

Chronic Patterns

  • Mild but persistent elevation might signal metabolic syndrome or fatty liver
  • ALT levels may decline in advanced liver disease (e.g., cirrhosis) due to loss of functional hepatocytes, which might be misleading if relying on ALT alone.
  • Even slightly elevated levels (but still "normal") may indicate increased cardiovascular risk
  • Very low ALT (< 10 U/L) may be linked to malnutrition, frailty, or vitamin B6 deficiency
  • Pattern over time matters more than single readings

Context Is Crucial

  • Consider alongside markers of metabolic health (glucose, lipids, etc.)
  • Look at inflammatory markers if available
  • Factor in body composition, diet, and lifestyle
  • Recent exercise or medications can temporarily affect levels

The goal isn't just to get ALT into the "normal" range but to understand what its patterns reveal about both liver and overall metabolic health.

Clinical Ranges

Female

  • 16–19 yr: 5 – 32 (U/L)
  • ≥ 20 yr: 6 – 29 (U/L)

Male

  • 16–19 yr: 8 – 46 (U/L)
  • ≥ 20 yr: 9 – 46 (U/L)

Lifestyle Factors That Can Impact It

Certain factors can help maintain healthy ALT levels, including:

  • Regular moderate exercise improves liver blood flow and reduces fat accumulation while supporting overall metabolic health.
  • A diet rich in omega-3s and fiber can reduce ALT.
  • Adequate sleep (7-9 hours) allows the liver to perform its vital detoxification and repair processes optimally.
  • Weight management, particularly gradual loss if overweight, reduces fat accumulation in the liver and improves its function.
  • Consistent hydration supports the liver's detoxification processes and helps maintain proper blood volume.
  • Regular meal timing helps maintain stable blood sugar and reduces stress on the liver's glucose regulation system.

Factors that may adversely affect levels include:

  • Binge drinking causes acute liver cell death and can lead to lasting damage even with otherwise healthy habits.
  • Rapid weight loss, especially through crash dieting, may overwhelm the liver with suddenly released toxins from fat tissue.
  • Over-the-counter pain medications (especially acetaminophen) taken at high doses can directly damage liver cells.
  • Certain herbal supplements and traditional medicines can cause unexpected liver injury due to unregulated compounds.
  • Mixing medications that stress the liver (even if each is safe alone) can lead to cumulative damage.
  • Sleep apnea has been tied to higher ALT levels
  • Extended fasting or very low-calorie diets can cause liver stress

Other Factors That Can Impact It

Certain genetic conditions can cause abnormal ALT levels, including:

  • Hemochromatosis: can affect liver function
  • Wilson's disease: can result in higher levels
  • Alpha-1 antitrypsin deficiency: may cause liver disease
  • Genetic variants affecting drug metabolism

Taking some medications and supplements may lead to a higher score on an ALT test, including:

  • Acetaminophen
  • Statins
  • Some antibiotics
  • Antifungal medications
  • Herbal supplements
  • High-dose vitamin A
  • Oral contraceptives

Some traditional medicines, such as cinnamon, may lower ALT levels.

Other factors that can make a difference in ALT levels include:

  • Age: Levels are often lower in older people.
  • Sex: ALT tends to be higher in males.
  • Body mass: A higher BMI can cause elevated levels.
  • Muscle mass: A higher muscle mass can also lead to higher ALT.
  • Pregnancy: Levels can vary by trimester.
  • Exercise: Recent exercise can raise levels (though long-term exercise lowers it)
  • Ethnicity: Hispanic people may have higher levels than white or Black people.

Testing Accuracy and Stability

ALT activity varies day to day by 10-30%. Within a given day, there is also significant diurnal variation, with ALT activities being up to 45% higher in the afternoon than in the early morning, so repeating testing at the same time is important.

Factors That May Cause Unreliable Results

  • Strenuous exercise within 24 hours can significantly increase levels.
  • A recent meal can influence your results.
  • The timing of your medications can also affect levels.
  • Dehydration can cause higher levels.

How It Relates to Other Markers

Your provider may compare your ALT results to other tests to get a more in-depth look at the health of your liver. Some of these tests might include:

  • Aspartate aminotransferase (AST): Testing for this enzyme can help determine the source and severity of liver damage through the AST/ALT ratio.
  • Alkaline phosphatase (ALP): Looking at levels of this enzyme helps distinguish between different types of liver disease, and particularly whether bile flow is affected.
  • Gamma-glutamyl transferase: This test aids in determining if elevated ALT is alcohol-related or due to a problem in the liver.
  • Total bilirubin: If total bilirubin and ALT are both elevated, this can be a sign that liver damage is more severe.
  • Albumin: This test provides information about the liver's synthetic function and helps evaluate whether liver disease is chronic.
  • Prothrombin time (PT): This looks at the liver's ability to produce clotting factors and can help measure the severity of liver dysfunction.
  • Complete blood count (CBC): A CBC can uncover any underlying infections, anemia, or other conditions affecting liver function.
  • Creatine kinase: This helps determine if high ALT might be from muscle damage rather than liver injury.
  • Hepatitis panel: This test is helpful in determining if viral hepatitis is causing high ALT.
  • Ferritin: This can identify high iron conditions that can cause liver damage and elevation of ALT.

Follow-Up Considerations

You should always talk to your doctor if you have medical concerns or questions.

When Re-Testing May be Appropriate

Depends on the clinician's input on the likely cause and interventions taken.

Monitoring Recommendations

  • Regular ALT testing until stable
  • Weight tracking
  • Medication review
  • Alcohol intake documentation
  • Diet and exercise log

Additional Testing Your Doctor May Consider

  • Complete hepatic panel
  • Viral hepatitis screening
  • Iron studies
  • Autoimmune markers
  • Imaging (ultrasound, CT or MRI)
  • Drug/alcohol screening if indicated
  • Lipid panel

When Additional Care May be Warranted

  • Rapid doubling of levels
  • Any elevation with symptoms
  • Persistent elevation >6 weeks
  • Multiple abnormal liver markers
  • Development of jaundice
  • New onset confusion

Further Reading

The 2025 Levels Guide to the liver and metabolic health

Bibliography

References

1. Chalasani, Naga, et al. "The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Diseases." Hepatology, vol. 67, no. 1, 2018, pp. 328-357. doi:10.1002/hep.29367.

2. Dufour, D. R., et al. "Diagnosis and Monitoring of Hepatic Injury. I. Performance Characteristics of Laboratory Tests." Clinical Chemistry, vol. 46, no. 12, 2000, pp. 2027-2049. doi:10.1093/clinchem/46.12.2027.

3. European Association for the Study of the Liver. "EASL Clinical Practice Guidelines: Management of Hepatocellular Carcinoma." Journal of Hepatology, vol. 69, no. 1, 2018, pp. 182-236. doi: 10.1016/j.jhep.2018.03.019.

4. Friedman, L. S. "Approach to the Patient with Abnormal Liver Biochemical and Function Tests." UpToDate, 2022.

5. Giannini, E. G., et al. "Liver Enzyme Alteration: A Guide for Clinicians." Canadian Medical Association Journal, vol. 172, no. 3, 2005, pp. 367-379. doi:10.1503/cmaj.1040752.

6. Gowda, S., et al. "A Review on Laboratory Liver Function Tests." Pan African Medical Journal, vol. 3, 2009, p. 17.

7. Green, R. M., and S. Flamm. "AGA Technical Review on the Evaluation of Liver Chemistry Tests." Gastroenterology, vol. 123, no. 4, 2002, pp. 1367-1384. doi:10.1053/gast.2002.36061.

8. Kim, W. R., et al. "Serum Activity of Alanine Aminotransferase (ALT) as an Indicator of Health and Disease." Hepatology, vol. 47, no. 4, 2008, pp. 1363-1370. doi:10.1002/hep.22109.

9. Kwo, P. Y., et al. "ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries." American Journal of Gastroenterology, vol. 112, no. 1, 2017, pp. 18-35. doi:10.1038/ajg.2016.517.

10. Lala, V., et al. "Liver Function Tests." StatPearls, 2023, StatPearls Publishing.

11. Newsome, P. N., et al. "Guidelines on the Management of Abnormal Liver Blood Tests." Gut, vol. 67, no. 1, 2018, pp. 6-19. doi:10.1136/gutjnl-2017-314924.

12. Ruhl, C. E., and J. E. Everhart. "Upper Limits of Normal for Alanine Aminotransferase Activity in the United States Population." Hepatology, vol. 55, no. 2, 2012, pp. 447-454. doi:10.1002/hep.24725.

13. Senior, J. R. "Alanine Aminotransferase: A Clinical and Regulatory Tool for Detecting Liver Injury---Past, Present, and Future." Clinical Pharmacology & Therapeutics, vol. 92, no. 3, 2012, pp. 332-339. doi:10.1038/clpt.2012.108.

14. Terrault, N. A., et al. "Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance." Hepatology, vol. 67, no. 4, 2018, pp. 1560-1599. doi:10.1002/hep.29800.

15. Wroblewski, F. "The Clinical Significance of Transaminase Activities of Serum." American Journal of Medicine, vol. 27, no. 6, 1959, pp. 911-923.

16. Wright, M. A., et al. "Consider Muscle Disease in Children with Elevated Transaminase." Journal of the American Board of Family Medicine, vol. 25, no. 4, 2012, pp. 536-540

Sign up for the Levels Newsletter